NCT04995666

Brief Summary

Quality and reliability study of hearing aid. Adults with mild to severe hearing loss will wear hearing aids daily for approximately 3 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 11, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

May 17, 2023

Completed
Last Updated

May 17, 2023

Status Verified

April 1, 2023

Enrollment Period

3 months

First QC Date

June 11, 2021

Results QC Date

March 31, 2023

Last Update Submit

April 24, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 1

    Test box electroacoustic measurements of hearing aid done at full on settings must meet manufacturer product specifications per manufacturer data sheet. This includes maximum and high frequency average output sound pressure level, maximum and high frequency average acoustic gain, frequency response range, total harmonic distortion and equivalent input noise level. This is done using an Audioscan Verifit2 electroacoustic analyzer. Electroacoustic measurements listed above will also be taken with hearing aid set to user settings, as a baseline measure for all future appointments.

    Day 1 of study

  • Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 45

    Test box electroacoustic measurements (using the Audioscan Verifit 2 Electroacoustic Analyzer) of hearing aid done at user gain settings after daily use for extended period of time. Results will be compared to baseline electroacoustic measures taken on day 1 of study. A "pass" means that devices were within tolerance levels (per ANSI S3.22-2014) of baseline measures. A "fail" means that devices were not within tolerance levels of one or more baseline measures (i.e. output, gain, frequency range, total harmonic distortion, or equivalent input noise level).

    Day 45 of study

  • Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 90

    Test box electroacoustic measurements of hearing aid done at user gain settings after daily use for extended period of time. Test box electroacoustic measurements of hearing aid done at user gain settings after daily use for extended period of time. Results will be compared to baseline electroacoustic measures taken on day 1 of study. A "pass" means that devices were within tolerance levels (per ANSI S3.22-2014) of baseline measures. A "fail" means that devices were not within tolerance levels of one or more baseline measures (i.e. output, gain, frequency range, total harmonic distortion, or equivalent input noise level).

    Day 90 of study

Study Arms (1)

Hearing Aid

EXPERIMENTAL

Participants will wear Phonak rechargeable Audeo hearing aids

Device: Phonak Audeo hearing aid

Interventions

Rechargeable hearing aid

Hearing Aid

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with mild to moderate severe sensorineural hearing loss
  • Adults who were able to incorporate some type of physical activity into their day (i.e walking, excercise, gardening, etc.)

You may not qualify if:

  • Unable or unwilling to wear study devices during a home trial
  • Unable or unwilling to come to lab for study visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova

Aurora, Illinois, 60504, United States

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Director of Research
Organization
Phonak Audiology Research Center

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2021

First Posted

August 9, 2021

Study Start

June 8, 2021

Primary Completion

September 13, 2021

Study Completion

October 31, 2021

Last Updated

May 17, 2023

Results First Posted

May 17, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations